Why are pharmacokinetic data summarized by arithmetic means?

Journal of Biopharmaceutical Statistics

Volumn 10, Issue 1, 2000, Pages 55-71

  Julious, Steven A ^a,b   Debarnot, Camille A M ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Clinical Pharmacology Statistics   (United Kingdom)

Author keywords

Arithmetic means; Bioequivalence pharmacokinetic data; Geometric means; Lognormal; Normal

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; DATA ANALYSIS; DERIVATIZATION; HALF LIFE TIME; MATHEMATICAL ANALYSIS; MAXIMUM ALLOWABLE CONCENTRATION; NORMAL VALUE; PHARMACOKINETICS; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AREA UNDER CURVE; DATA INTERPRETATION, STATISTICAL; FOOD-DRUG INTERACTIONS; HALF-LIFE; HUMANS; MATHEMATICS; PHARMACOKINETICS;

EID: 0033995308     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-100101013     Document Type: Article

References (19)

1. Rowland M, Tozer TN: Clinical Pharmacokinetics, Concepts and Applications, Lea & Febiger, London, 1989.
2. Lacey LF, Keene ON, Pritchard JF, Bye A: "Common Non-compartmental Pharmacokinetic Variables: Are They Normally or Log-Normally Distributed?" J. Biopharm. Stat., 7(1), 171-178, 1997.
3. Mizuta E, Tsubotani A: "Preparation of Mean Drug Concentration-Time Curves in Plasma. A Study on the Frequency Distribution of Pharmacokinetic Parameters," Chem. Pharm. Bull., 33(4), 1620-1632, 1985.
4. Cartwright AC: "Consensus Statement on Bioavailability Test Requirements and Standards," Drug Information J., 25, 473-482, 1991.
5. "CPMP Guideline: Investigation of Bioavailability and Bioequivalence," Doc. III/54/89-EN, CPMP, London, England, 1992.
6. "Guidance: Statistical Procedures for Bioequivalence Studies Using a Standard Two Treatment Cross-Over Design," Office of Generic Drugs, FDA, Washington, D.C., July 1992.
7. Hauschke D, Steinijans VW: "Modified-Release Dosage Forms: Acceptance Criteria and Statistics for Bioequivalence," Drug Information J., 27, 903-909, 1993.
8. Keene ON: "The Log Transformation Is Special," Stat. in Medicine, 14, 811-819, 1995.
9. SAS Language: Reference, Version 6, 1st Ed., SAS Institute, Inc. Cary, NC, 1990.
10. Julious SA, Mullee MA: "Confounding and Simpson's Paradox," British Med. J., 309, 1480-1481, 1994.
11. Chinn S: "Choosing a Transformation," J. Appl. Stat., 23(4), 395-404, 1996.
12. Chinn S: "Scale, Parametric Methods and Transformations," Stat. in Medicine, 46, 536-538, 1991.
13. Armitage P, Berry G: Statistical Methods in Medical Research, Blackwell Scientific Publications, Oxford, England, 1987.
14. Wetherill GB: Intermediate Statistical Methods, Chapman and Hall, London, England, 1981.
15. Kupferschmidt HHT, Fattinger KE, Ha H, Follath F, Krahenbuhl S: "Grapefruit Juice Enhances the Bioavailibility of the HIV Protease Inhibitor Saquinavir in Man," British J. Clin. Pharm., 45, 355-359, 1998.
16. Altman DG, Bland JM: "Detecting Skewness from Summary Information," British Med. J., 313, 1200, 1996.
17. Swinscow TDV (revised by Campbell MJ): Statistics at Square One, BMJ, London, England, 1997.
18. Diletti E, Hauschke D, Steinijans VW: "Sample Size Determination for Bioequivalence Assessment by Means of Confidence Intervals," Int. J. Clin. Pharm., Therapy and Toxicol., 29, 1-8, 1991.
19. Campbell MJ, Julious SA, Altman DG: "Estimating Sample Sizes for Binary, Ordered Categorical and Continuous Outcomes in Two Group Comparisons," British Med. J., 311, 1145-1148, 1995.